Your browser doesn't support javascript.
loading
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study.
Salles, Gilles; Schuster, Stephen J; de Vos, Sven; Wagner-Johnston, Nina D; Viardot, Andreas; Blum, Kristie A; Flowers, Christopher R; Jurczak, Wojciech J; Flinn, Ian W; Kahl, Brad S; Martin, Peter; Kim, Yeonhee; Shreay, Sanatan; Will, Matthias; Sorensen, Bess; Breuleux, Madlaina; Zinzani, Pier Luigi; Gopal, Ajay K.
Afiliação
  • Salles G; Hospices Civils de Lyon, University Claude Bernard, Pierre Benite, France.
  • Schuster SJ; Lymphoma Program, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA.
  • de Vos S; Department of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Wagner-Johnston ND; Departments of Oncology and Hematologic Malignancies, Johns Hopkins University, Baltimore, MD, USA.
  • Viardot A; Department of Internal Medicine III, University Hospital of Ulm, Germany.
  • Blum KA; Division of Hematology, Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Flowers CR; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Jurczak WJ; Department of Hematology, Jagiellonian University, Krakow, Poland.
  • Flinn IW; Hematologic Malignancies Research Program, Sarah Cannon Research Institute, Nashville, TN, USA.
  • Kahl BS; Department of Medicine, Oncology Division, Washington University School of Medicine, St Louis, MO, USA.
  • Martin P; Division of Hematology/Oncology, Weill Cornell Medical College, NY, USA.
  • Kim Y; Gilead Sciences Inc., Foster City, CA, USA.
  • Shreay S; Gilead Sciences Inc., Foster City, CA, USA.
  • Will M; At the time of the analyses, Gilead Sciences Inc., Foster City, CA, USA.
  • Sorensen B; At the time of the analyses, Gilead Sciences Inc., Foster City, CA, USA.
  • Breuleux M; At the time of the analyses, Gilead Sciences Inc., Foster City, CA, USA.
  • Zinzani PL; Institute of Hematology and Oncology, University of Bologna, Italy.
  • Gopal AK; Medical Oncology Division, University of Washington School of Medicine, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA agopal@u.washington.edu.
Haematologica ; 102(4): e156-e159, 2017 04.
Article em En | MEDLINE | ID: mdl-27979923
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Purinas / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Alquilantes / Quinazolinonas / Rituximab Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Purinas / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Alquilantes / Quinazolinonas / Rituximab Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article